{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:44:37Z","timestamp":1779893077902,"version":"3.53.1"},"reference-count":11,"publisher":"Informa UK Limited","issue":"17","funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["CTRQQR-2021\\100003"],"award-info":[{"award-number":["CTRQQR-2021\\100003"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Bioanalysis"],"published-print":{"date-parts":[[2025,9,2]]},"DOI":"10.1080\/17576180.2025.2554564","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T09:56:52Z","timestamp":1760695012000},"page":"1105-1112","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Development and validation of an LC-MS\/MS method for the quantification of novel therapeutic TT-478, a selective adenosine receptor 2B antagonist, for a phase I\/II clinical trial"],"prefix":"10.1080","volume":"17","author":[{"given":"Daniel","family":"Whitaker","sequence":"first","affiliation":[{"name":"Newcastle University Centre for Cancer, Newcastle University","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Francis","sequence":"additional","affiliation":[{"name":"Newcastle University Centre for Cancer, Newcastle University","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sami","family":"Karaborni","sequence":"additional","affiliation":[{"name":"Teon Therapeutics","place":["Redwood City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Smith","sequence":"additional","affiliation":[{"name":"Teon Therapeutics","place":["Redwood City, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny L.","family":"Craigen","sequence":"additional","affiliation":[{"name":"Cancer Research UK Centre for Drug Development","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svatopluk","family":"Svetlik","sequence":"additional","affiliation":[{"name":"Cancer Research UK Centre for Drug Development","place":["London, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelby","family":"Barnett","sequence":"additional","affiliation":[{"name":"Newcastle University Centre for Cancer, Newcastle University","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1897-8678","authenticated-orcid":false,"given":"Gareth J.","family":"Veal","sequence":"additional","affiliation":[{"name":"Newcastle University Centre for Cancer, Newcastle University","place":["Newcastle upon Tyne, UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"e_1_3_8_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.34622"},{"key":"e_1_3_8_4_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-99286-0_7"},{"key":"e_1_3_8_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-1241.2011.02799.x"},{"key":"e_1_3_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.06.106"},{"key":"e_1_3_8_7_1","doi-asserted-by":"publisher","DOI":"10.1186\/s40425-018-0360-8"},{"issue":"3","key":"e_1_3_8_8_1","first-page":"2077","article-title":"Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist","volume":"23","author":"Fishman P","year":"2003","unstructured":"Fishman P, Bar-Yehuda S, Ardon E, et al. Targeting the A3 adenosine receptor for cancer therapy: inhibition of prostate carcinoma cell growth by A3AR agonist. Anticancer Res. 2003;23(3a):2077\u20132083.","journal-title":"Anticancer Res"},{"key":"e_1_3_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189005"},{"key":"e_1_3_8_10_1","volume-title":"Bioanalytical method validation: guidance for industry 2018","author":"US FDA","unstructured":"US FDA. Bioanalytical method validation: guidance for industry 2018. https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf"},{"key":"e_1_3_8_11_1","unstructured":"Ich harmonized guideline - bioanalytical method validation and study sample analysis M10 2022. https:\/\/www.ema.europa.eu\/en\/documents\/scientific-guideline\/ich-guideline-m10-bioanalytical-method-validation-step-5_en.pdf"},{"key":"e_1_3_8_12_1","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2022-SITC2022.0585"},{"key":"e_1_3_8_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djad091"}],"container-title":["Bioanalysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17576180.2025.2554564","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T11:44:23Z","timestamp":1760787863000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17576180.2025.2554564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,2]]},"references-count":11,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025,9,2]]}},"alternative-id":["10.1080\/17576180.2025.2554564"],"URL":"https:\/\/doi.org\/10.1080\/17576180.2025.2554564","relation":{},"ISSN":["1757-6180","1757-6199"],"issn-type":[{"value":"1757-6180","type":"print"},{"value":"1757-6199","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,2]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ibio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-08-21","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}